{"title":"人工冷冻-解冻胚胎移植(FET)周期中 LH 上升的影响。","authors":"Samer Khoury, Einav Kadour-Peero, Ilan Calderon","doi":"10.1530/RAF-21-0017","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the association between a rise in serum luteinizing hormone (LH) levels during artificial frozen-thawed embryo transfer (FET) cycles and clinical pregnancy rate.</p><p><strong>Methods: </strong>A retrospective cohort study of women undergoing artificial FET cycles. We compared cycles in which LH double itself from the early follicular phase and further (group A) to cycles without a rise in LH (group B). Endometrium preparation was achieved by administration of 2 mg three times per day estradiol valerate tablets. Embryo transfer (ET) was conducted after achieving endometrial thickness > 7 mm and vaginal progesterone was added according to the embryo's age. A beta-hCG was measured 13-14 days after ET. Clinical pregnancy was diagnosed on transvaginal ultrasound.</p><p><strong>Results: </strong>Data from 984-FET cycles were retrieved. LH, exogenous estradiol (E2), progesterone values, endometrial thickness, and pregnancy outcomes were available in all patients. From 984-FET cycles, 629 (63.9%) had a doubling, and 355 (36.07%) had no rise in LH. Patients mean age was 30 years, similar in both groups. A multivariable logistic regression analysis was calculated to assess the effect of LH rise and pregnancy outcomes, after adjusting for confounders including a rise in E2 level and endometrial thickness. In this model, there was no association between doubling LH values and pregnancy rates (adjusted odds ratio: 1.06, 95% CI: 0.75-1.5, <i>P</i> = 0.74).</p><p><strong>Conclusion: </strong>LH rise during artificial FET cycles does not alter pregnancy rates. Apparently, hormonal monitoring of LH levels may not yield useful information in the artificial FET cycle and may be omitted.</p><p><strong>Lay summary: </strong>Supplementation of estradiol, a hormone produced by the ovaries, starting at the beginning of the menstrual cycle of an artificially frozen embryo transfer (FET) can lead to a rise in luteinizing hormone (LH), the hormone that induces ovulation. Such a rise in LH may interfere with embryo implantation, the process where the embryo attaches to the inner lining of the uterus and, therefore, could affect the chances of pregnancy. The current study is the first to assess the effect of a dynamic rise in LH levels during FET cycles on pregnancy rates. This study found no difference in pregnancy rates between FET cycles where the LH doubled compared to cycles without such a rise in LH. Larger, prospective studies should be conducted to assess the impact of LH elevation on pregnancy outcomes.</p>","PeriodicalId":21128,"journal":{"name":"Reproduction & Fertility","volume":"2 3","pages":"231-235"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d2/57/RAF-21-0017.PMC8801030.pdf","citationCount":"0","resultStr":"{\"title\":\"The effect of LH rise during artificial frozen-thawed embryo transfer (FET) cycles.\",\"authors\":\"Samer Khoury, Einav Kadour-Peero, Ilan Calderon\",\"doi\":\"10.1530/RAF-21-0017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To evaluate the association between a rise in serum luteinizing hormone (LH) levels during artificial frozen-thawed embryo transfer (FET) cycles and clinical pregnancy rate.</p><p><strong>Methods: </strong>A retrospective cohort study of women undergoing artificial FET cycles. We compared cycles in which LH double itself from the early follicular phase and further (group A) to cycles without a rise in LH (group B). Endometrium preparation was achieved by administration of 2 mg three times per day estradiol valerate tablets. Embryo transfer (ET) was conducted after achieving endometrial thickness > 7 mm and vaginal progesterone was added according to the embryo's age. A beta-hCG was measured 13-14 days after ET. Clinical pregnancy was diagnosed on transvaginal ultrasound.</p><p><strong>Results: </strong>Data from 984-FET cycles were retrieved. LH, exogenous estradiol (E2), progesterone values, endometrial thickness, and pregnancy outcomes were available in all patients. From 984-FET cycles, 629 (63.9%) had a doubling, and 355 (36.07%) had no rise in LH. Patients mean age was 30 years, similar in both groups. A multivariable logistic regression analysis was calculated to assess the effect of LH rise and pregnancy outcomes, after adjusting for confounders including a rise in E2 level and endometrial thickness. In this model, there was no association between doubling LH values and pregnancy rates (adjusted odds ratio: 1.06, 95% CI: 0.75-1.5, <i>P</i> = 0.74).</p><p><strong>Conclusion: </strong>LH rise during artificial FET cycles does not alter pregnancy rates. Apparently, hormonal monitoring of LH levels may not yield useful information in the artificial FET cycle and may be omitted.</p><p><strong>Lay summary: </strong>Supplementation of estradiol, a hormone produced by the ovaries, starting at the beginning of the menstrual cycle of an artificially frozen embryo transfer (FET) can lead to a rise in luteinizing hormone (LH), the hormone that induces ovulation. Such a rise in LH may interfere with embryo implantation, the process where the embryo attaches to the inner lining of the uterus and, therefore, could affect the chances of pregnancy. The current study is the first to assess the effect of a dynamic rise in LH levels during FET cycles on pregnancy rates. This study found no difference in pregnancy rates between FET cycles where the LH doubled compared to cycles without such a rise in LH. Larger, prospective studies should be conducted to assess the impact of LH elevation on pregnancy outcomes.</p>\",\"PeriodicalId\":21128,\"journal\":{\"name\":\"Reproduction & Fertility\",\"volume\":\"2 3\",\"pages\":\"231-235\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d2/57/RAF-21-0017.PMC8801030.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reproduction & Fertility\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1530/RAF-21-0017\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproduction & Fertility","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1530/RAF-21-0017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:评估人工冷冻-解冻胚胎移植(FET)周期中血清黄体生成素(LH)水平上升与临床妊娠率之间的关系:对接受人工冻融胚胎移植周期的女性进行回顾性队列研究。我们比较了LH从早期卵泡期开始翻倍的周期(A组)和LH没有上升的周期(B组)。子宫内膜准备是通过每天三次服用 2 毫克戊酸雌二醇片来实现的。在子宫内膜厚度大于 7 毫米后进行胚胎移植(ET),并根据胚胎年龄添加阴道黄体酮。ET后13-14天测量β-hCG。经阴道超声诊断临床妊娠:结果:检索了 984 个 ET 周期的数据。所有患者的 LH、外源性雌二醇(E2)、孕酮值、子宫内膜厚度和妊娠结果均可获得。在 984 个 FET 周期中,629 例(63.9%)患者的 LH 增加了一倍,355 例(36.07%)患者的 LH 没有增加。患者的平均年龄为 30 岁,两组患者的平均年龄相似。在调整了 E2 水平上升和子宫内膜厚度等混杂因素后,计算了多变量逻辑回归分析,以评估 LH 上升和妊娠结局的影响。在该模型中,LH值翻倍与妊娠率之间没有关联(调整后的几率比:1.06,95% CI:0.75-1.5,P = 0.74):结论:人工 FET 周期中 LH 值的升高不会改变妊娠率。总结:在人工冷冻胚胎移植(FET)的月经周期开始时补充雌二醇(一种由卵巢分泌的激素),可导致黄体生成素(LH)(一种诱导排卵的激素)升高。LH 的升高可能会影响胚胎植入,即胚胎附着在子宫内膜上的过程,从而影响怀孕的机会。目前的研究首次评估了 FET 周期中 LH 水平动态上升对怀孕率的影响。该研究发现,LH 水平翻倍的 FET 周期与 LH 水平未升高的周期相比,怀孕率没有差异。应进行更大规模的前瞻性研究,以评估 LH 升高对妊娠结果的影响。
The effect of LH rise during artificial frozen-thawed embryo transfer (FET) cycles.
Purpose: To evaluate the association between a rise in serum luteinizing hormone (LH) levels during artificial frozen-thawed embryo transfer (FET) cycles and clinical pregnancy rate.
Methods: A retrospective cohort study of women undergoing artificial FET cycles. We compared cycles in which LH double itself from the early follicular phase and further (group A) to cycles without a rise in LH (group B). Endometrium preparation was achieved by administration of 2 mg three times per day estradiol valerate tablets. Embryo transfer (ET) was conducted after achieving endometrial thickness > 7 mm and vaginal progesterone was added according to the embryo's age. A beta-hCG was measured 13-14 days after ET. Clinical pregnancy was diagnosed on transvaginal ultrasound.
Results: Data from 984-FET cycles were retrieved. LH, exogenous estradiol (E2), progesterone values, endometrial thickness, and pregnancy outcomes were available in all patients. From 984-FET cycles, 629 (63.9%) had a doubling, and 355 (36.07%) had no rise in LH. Patients mean age was 30 years, similar in both groups. A multivariable logistic regression analysis was calculated to assess the effect of LH rise and pregnancy outcomes, after adjusting for confounders including a rise in E2 level and endometrial thickness. In this model, there was no association between doubling LH values and pregnancy rates (adjusted odds ratio: 1.06, 95% CI: 0.75-1.5, P = 0.74).
Conclusion: LH rise during artificial FET cycles does not alter pregnancy rates. Apparently, hormonal monitoring of LH levels may not yield useful information in the artificial FET cycle and may be omitted.
Lay summary: Supplementation of estradiol, a hormone produced by the ovaries, starting at the beginning of the menstrual cycle of an artificially frozen embryo transfer (FET) can lead to a rise in luteinizing hormone (LH), the hormone that induces ovulation. Such a rise in LH may interfere with embryo implantation, the process where the embryo attaches to the inner lining of the uterus and, therefore, could affect the chances of pregnancy. The current study is the first to assess the effect of a dynamic rise in LH levels during FET cycles on pregnancy rates. This study found no difference in pregnancy rates between FET cycles where the LH doubled compared to cycles without such a rise in LH. Larger, prospective studies should be conducted to assess the impact of LH elevation on pregnancy outcomes.